Abstract:e23506 Background: The gastrointestinal stromal tumor (GIST) is a potentially malignant mesenchymal tumor (sarcoma), whose management has been transformed by approvals of TKIs. However, recurrence or metastasis is a formidable challenge in managing high-risk GIST. Comprehensive investigation of the transcriptome and genome in GIST is helpful to determine the therapy strategy for patients. This study aims to explore the molecular features of high-risk recurrence GIST. Methods: The tumor tissue samples of 42 patients with primary GIST were collected, in which all patients were divided into low-risk (n = 12), intermediate-risk (n = 11), and high-risk (n = 19) groups according to the NIH 2017 th , in which 8 developed recurrence within three years and 11 without recurrence over three years in the high-risk group. Tumor-normal whole-exome and tumor mRNA sequencing was performed on baseline tissue DNA isolated from all patients. Results: Consistent with prior knowledge, KIT was the predominant mutation. The top mutated genes in GISTs were KIT (82%), PHLDA1 (39%), MUC6 (22%), ARID1B(20%), SURF2(20%), MGA(16%), MUC17(16%), MPRIP(16%) and PDGFRA(16%), which MUC6 was a significantly different mutation gene (DMG) associated with disease progression in terms of either high-risk(p = 0.04), recurrence(p = 0.02) or progression(p = 0.05). Interestingly, PDGFRA mutation co-occurs with CTNND2(p 0.05). Notably, del_NCOR1 or amp_NCOR1 was uniquely observed in the recurrence group. Compared with non-recurrence GIST, gene expression profiles revealed that mast cell activate (MCA),M1-macrophages infiltration were higher in recurrence group, and mRNA was significantly upregulated in Systemic lupus erythematosus、Neutrophil extracellular trap formation、Viral carcinogenesis、Endocytosis. These pathways were indentified as being associated with recurrence and progression in other cancer studies. For example, the endocytosis pathway expression is positively associated with oncogenic pathway signaling in CRC, and neutrophil extracellular trap on cancer cells promotes liver metastasis in the tumor microenvironment. In the other, NCOR1 is a crucial regulator of T cell and B cell development. Conclusions: Here, we demonstrated the DNA/RNA profiles of GISTs. We observed higher CNVs in high-risk GIST. Especially, the high-risk recurred tumor presented different CNVs frequency and microenvironment. These results may contribute to understanding the mechanism of recurrence and improving recurrence detection.

Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis

Involvement of genetic instability in the downregulation of sFRP1 in Chinese patients with hepatocellular carcinoma.

Expression Of Shh Signaling Pathway Factors In Gastrointestinal Stromal Tumor Tissues And Their Associations With Clinical Pathological Factors

Loss of Chromosome 9p21 and Decreased P16 Expression Correlate with Malignant Gastrointestinal Stromal Tumor

Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors

Altered Expression of ETV1 and Its Contribution to Tumorigenic Phenotypes in Gastrointestinal Stromal Tumors.

Mutational Characteristics of Gastrointestinal Stromal Tumors: A Single-Center Analysis of 302 Patients

Comprehensive genomic and transcriptomic profiling analysis of the recurrent gastrointestinal stromal tumor (GIST).

Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.

Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions

Comprehensive analysis of factors that involve in survival and prognosis in patients with gastrointestinal stromal tumors

Genetic Aberrations Of Gastrointestinal Stromal Tumors

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

Impact of Kit and Pdgfra Gene Mutations on Prognosis of Patients with Gastrointestinal Stromal Tumors after Complete Primary Tumor Resection

Molecular Portrait of GISTs Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma

Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors.

Whole-exome sequencing analysis of mutation characteristics in recurrent or metastatic gastrointestinal stromal tumors

Exon 11 Homozygous Mutations And Intron 10/Exon 11 Junction Deletions In The Kit Gene Are Associated With Poor Prognosis Of Patients With Gastrointestinal Stromal Tumors

[Molecular Mechanism of Gastrointestinal Stromal Tumors and Progress in Drug Research].

Clinical and prognostic significance of CC chemokine receptor type 8 protein expression in gastrointestinal stromal tumors